OMRON Corp. (OMRNY)
39.39
-0.23
(-0.58%)
USD |
OTCM |
Aug 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 7.745B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 51.19% |
| Valuation | |
| PE Ratio | 37.53 |
| PE Ratio (Forward) | |
| PS Ratio | 1.516 |
| Price to Book Value | 1.513 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.328 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 78.38% |
Profile
| OMRON Corp. engages in the manufacture and sale of automation components, equipment, and systems. It operates through the following segments: Industrial Automation, Healthcare, Social Systems Solutions & Services and Data Solutions Business. The Industrial Automation Business segment programmable controllers, motion control equipment, sensor equipment, industrial cameras and code readers, inspection equipment, safety equipment, industrial robots, etc. The Healthcare Business segment electronic blood pressure monitors, nebulizers, low-frequency therapy devices, electrocardiographs, oxygen concentrators, electronic thermometers, body composition scales, pedometers/activity trackers, electric toothbrushes, pulse oximeters, massagers, blood glucose meters, arteriosclerosis testing equipment, remote patient monitoring systems, telemedicine services, etc. The Social Systems Solutions & Services Business segment energy, mobility, IoT, M&S etc. The Data Solutions Business segment data healthcare, corporate health, M&S, data utilization solutions, independent living support business, etc. The company was founded by Kazuma Tateisi on May 10, 1933 and is headquartered in Kyoto, Japan. |
| URL | http://www.omron.co.jp |
| Investor Relations URL | https://www.omron.com/global/en/ir/ |
| HQ State/Province | Kyoto |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Small Cap Value |
| Next Earnings Release | Nov. 05, 2026 (est.) |
| Last Earnings Release | Aug. 05, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2019 |
Profile
| OMRON Corp. engages in the manufacture and sale of automation components, equipment, and systems. It operates through the following segments: Industrial Automation, Healthcare, Social Systems Solutions & Services and Data Solutions Business. The Industrial Automation Business segment programmable controllers, motion control equipment, sensor equipment, industrial cameras and code readers, inspection equipment, safety equipment, industrial robots, etc. The Healthcare Business segment electronic blood pressure monitors, nebulizers, low-frequency therapy devices, electrocardiographs, oxygen concentrators, electronic thermometers, body composition scales, pedometers/activity trackers, electric toothbrushes, pulse oximeters, massagers, blood glucose meters, arteriosclerosis testing equipment, remote patient monitoring systems, telemedicine services, etc. The Social Systems Solutions & Services Business segment energy, mobility, IoT, M&S etc. The Data Solutions Business segment data healthcare, corporate health, M&S, data utilization solutions, independent living support business, etc. The company was founded by Kazuma Tateisi on May 10, 1933 and is headquartered in Kyoto, Japan. |
| URL | http://www.omron.co.jp |
| Investor Relations URL | https://www.omron.com/global/en/ir/ |
| HQ State/Province | Kyoto |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Equity Style | Small Cap Value |
| Next Earnings Release | Nov. 05, 2026 (est.) |
| Last Earnings Release | Aug. 05, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 27, 2019 |